GSK3B and liver dysplastic nodule: Recent studies have shown that dapagliflozin acts as a nephroprotective agent for DN by counteracting hsa_circRNA_012448-has-miR-29b-2-5p-GSK3β pathway-mediated oxidative stress (Song et al., 2022), and has-miR-29b-2-5p expression was also screened in our mRNA-miRNA network.